China Resources Pharmaceutical Group Ltd. holds an effective interest of approximately 26.12% in China Resources Jiangzhong Pharmaceutical Co., Ltd. (Jiangzhong Pharmaceutical), which is accounted for as a subsidiary of the company. Jiangzhong Pharmaceutical, listed on the Shanghai Stock Exchange, released its unaudited preliminary financial information for the year ended 31 December 2025. For the reporting period, the company recorded total operating revenue of RMB 4.2195 billion, an operating profit of RMB 1.1985 billion, and net profit attributable to shareholders of RMB 906.12 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260123-11999917), on January 23, 2026, and is solely responsible for the information contained therein.